Hantavirus vaccine in 2026?
Amount
Buy
The question is whether “Hantavirus vaccine in 2026?” occurs by the stated deadline and under the published conditions.
A Yes outcome requires the stated conditions to be met; No covers the alternative.
The qualifying event, evidence source, cutoff time, and any exceptions are documented in the Resolution Rules below.
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.